- German DAX continues losing streak
- BMW Uncovers Russian Export Irregularities
- Deutsche Bank Securities Settles SEC Investigation
- Merck Finalizes LaNova Medicines Agreement
General market situation: European markets are trading mostly lower, with the Spanish SPA35 showing the largest decline (-0.63%), followed by the Dutch NED25 (-0.59%) and the pan-European EU50 (-0.47%). The French FRA40 and Italian ITA40 are both down 0.40%, while the UK's UK100 (-0.31%) and German DE40 (-0.30%) show more modest losses. In contrast, the Swiss SUI20 (+0.01%), Austrian AUT20 (+0.03%), and Polish W20 (+0.67%) are trading in positive territory.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Dax Returns by Sector. Source: Bloomberg Financial LP
Looking at the German DAX sector performance, only Financials (+0.18%) and Industrials (+0.08%) are trading in positive territory. Health Care shows the steepest decline (-0.76%), followed by Consumer Staples (-0.64%) and Consumer Discretionary (-0.54%). Information Technology (-0.38%), Materials (-0.35%), and Real Estate (-0.17%) are also down significantly. Communication Services (-0.07%) and Utilities (-0.11%) show more modest declines. The aggregate DAX performance shows a decline of 0.15%, with market breadth negative as eight out of ten sectors trade lower.
Volatility is currently observed in the broader European market. Source: xStation
The German DE40 Index is continuing its downtrend. The RSI has cooled down and is starting bearish divergence. Additionally, the MACD, after forming a bearish crossover, is widening to the downside.
For bears, a retest of the October high at 19,783 could accelerate the downward momentum. A decisive break below this level could lead to a retest of the early November high at 19,525, which aligns closely with the 50-day SMA at 19,653, establishing a critical support zone.
For bulls, the 161.8% Fibonacci retracement level at 20,566 remains the key resistance. This level has played a pivotal role in recent sessions and could act as either a springboard for further bullish advances or a threshold marking the onset of bearish divergence. Source: xStation
Corporate News
- BMW (BMW.DE) Uncovers Russian Export Irregularities - BMW has discovered unauthorized exports of over 100 high-end vehicles to Russia through its Hanover branch, leading to immediate termination of involved personnel and export suspension. While BMW affirms its compliance with EU and US sanctions, the company acknowledges the broader industry challenge of "grey imports" reaching Russia despite embargo measures. The luxury automaker is implementing additional controls to prevent unauthorized distribution channels.
- Deutsche Bank Securities (DBK.DE) Settles SEC Investigation - The broker-dealer subsidiary has agreed to pay $4 million to resolve SEC allegations regarding delayed suspicious activity reporting. The investigation revealed instances where the firm took over two years to file reports, including one case involving 68 suspicious transactions totaling nearly $2 billion. Deutsche Bank emphasized its cooperation with regulators and prior implementation of remedial measures.
- Volkswagen (VOW1.DE) Reaches Landmark Union Agreement - The automaker has concluded negotiations with IG Metall, securing a comprehensive restructuring deal that guarantees German factory operations through 2030 while planning for 35,000 job reductions through attrition. The agreement includes union concessions on wage increases until 2031 and production cuts, reflecting broader challenges in the German automotive sector amid economic headwinds and increasing Chinese competition.
- Merck (MRK.DE) Finalizes LaNova Medicines Agreement - The company has completed its exclusive global licensing deal for LM-299, a PD-1/VEGF bispecific antibody. Merck will record a Q4 2024 charge of $588M (18 cents per share) for the upfront payment, with potential additional milestone payments of up to $2.7B. The agreement includes a $300M technology transfer payment expected in 2025.
Other news coming from individual DAX index companies. Source: Bloomberg Financial LP
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
